Skip to content
matinvaramin

matinvaramin

matinvaramin

  • Home
  • Investment
  • Technology
  • Entertainment
  • Politics
  • Toggle search form

Tag: Products/Services

Opinion: A revolution on the supply side is needed to defeat inflation without crushing the global economy

Posted on July 1, 2022 By admin No Comments on Opinion: A revolution on the supply side is needed to defeat inflation without crushing the global economy
Opinion: A revolution on the supply side is needed to defeat inflation without crushing the global economy

MILAN, Italy (Project Syndicate) entCentral banks’ efforts to contain high and rising inflation are fueling headwinds to growth and are threatening to tip the global economy into recession. But the proximate cause of today’s inflationary pressures is a large, broad-based, and persistent imbalance between supply and demand. Higher interest rates will dampen demand, but supply-side…

Read More “Opinion: A revolution on the supply side is needed to defeat inflation without crushing the global economy” »

Investment

COVID vaccines for kids under 5 – what parents need to know

Posted on June 25, 2022 By admin No Comments on COVID vaccines for kids under 5 – what parents need to know
COVID vaccines for kids under 5 – what parents need to know

The Food and Drug Administration and the Centers for Disease Control and Prevention have both authorized Pfizer PFE, + 2.99% and Moderna’s MRNA, + 0.71% COVID-19 vaccines for kids under 5, and the Biden administration said that 10 million initial COVID vaccination doses could start being administered to young children beginning Tuesday, June 21. The…

Read More “COVID vaccines for kids under 5 – what parents need to know” »

Investment

FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them

Posted on June 17, 2022 By admin No Comments on FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them
FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them

The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and by Moderna for children as young as 6 months on Friday, adding the final group to the nation’s vaccine program. The regulator said Moderna’s MRNA The two-dose vaccine is now authorized…

Read More “FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them” »

Investment

‘4 companies have gained control over the formula market’: Lawmakers and women’s health advocates debate solutions to baby-formula shortage

Posted on June 17, 2022 By admin No Comments on ‘4 companies have gained control over the formula market’: Lawmakers and women’s health advocates debate solutions to baby-formula shortage
‘4 companies have gained control over the formula market’: Lawmakers and women’s health advocates debate solutions to baby-formula shortage

What can be done to prevent shortages of baby formula, tampons and other consumer products? The US Senate’s Competition Policy, Antitrust, and Consumer Rights Subcommittee held a hearing this week to look at the baby-formula market in the US, and broader issue of supply-chain issues. A national infant formula shortage has forced some desperate parents…

Read More “‘4 companies have gained control over the formula market’: Lawmakers and women’s health advocates debate solutions to baby-formula shortage” »

Investment

FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency

Posted on June 15, 2022 By admin No Comments on FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency
FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency

A day after a panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the same panel will reconvene to discuss vaccines for children under the age of five, the final group to be added to the US program. The group voted unanimously that…

Read More “FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency” »

Investment

FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID

Posted on June 14, 2022 By admin No Comments on FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID
FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID

An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna MRNA, + 2.18% The vaccine could become a second choice for children in that age group, along…

Read More “FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID” »

Investment

The ‘cost to build a home in the US has risen at an unprecedented rate,’ says BofA

Posted on June 11, 2022 By admin No Comments on The ‘cost to build a home in the US has risen at an unprecedented rate,’ says BofA
The ‘cost to build a home in the US has risen at an unprecedented rate,’ says BofA

House prices have been ballistic over the last two years, in part due to a big shortage in housing materials. A new report lays out what elements actually go into building a home, highlighting how complicated – and expensive – the process can get. “In the last three years, the cost to build a home…

Read More “The ‘cost to build a home in the US has risen at an unprecedented rate,’ says BofA” »

Investment

Dow up nearly 300 points, Nasdaq leads stocks higher despite Microsoft cutting guidance

Posted on June 2, 2022 By admin No Comments on Dow up nearly 300 points, Nasdaq leads stocks higher despite Microsoft cutting guidance
Dow up nearly 300 points, Nasdaq leads stocks higher despite Microsoft cutting guidance

Stocks turned higher Thursday, shrugging off earlier weakness, after Microsoft Corp. cut its fourth-quarter guidance ahead of the opening bell, citing the toll taken by a surging US dollar. Investors were also digesting comments from several Federal Reserve officials, labor-market data and a decision by OPEC + members to boost daily oil production. How are…

Read More “Dow up nearly 300 points, Nasdaq leads stocks higher despite Microsoft cutting guidance” »

Investment

Excitement in Shanghai as officials promise reopening after two-month lockdown, and cases continue to flatten in U.S. Northeast

Posted on May 31, 2022 By admin No Comments on Excitement in Shanghai as officials promise reopening after two-month lockdown, and cases continue to flatten in U.S. Northeast
Excitement in Shanghai as officials promise reopening after two-month lockdown, and cases continue to flatten in U.S. Northeast

There was excitement in Shanghai Tuesday after officials said they would take some major steps Wednesday toward reopening and ending the two-month COVID-19 lockdown in China’s largest city that has kept most residents confined to their homes. Full bus and subway service will be restored as will basic rail connections with the rest of China,…

Read More “Excitement in Shanghai as officials promise reopening after two-month lockdown, and cases continue to flatten in U.S. Northeast” »

Investment

Archives

  • July 2022
  • June 2022
  • May 2022

Categories

  • Entertainment
  • Investment
  • Politics
  • Technology

Recent Posts

  • a marvel of a miniature gaming PC
  • Current Mortgage Rates for Jul. 4, 2022: Rates Retreat
  • How Fantasia and Final Fantasy collide in this stupendous OST
  • Refinance Rates for Jul. 4, 2022: Rates Decline
  • Opinion: We are thinking about AR/VR wrong

Recent Comments

No comments to show.
  • About us
  • Contact us
  • DMCA
  • Privacy policy
  • Terms and conditions

Copyright © 2022 matinvaramin.

Powered by PressBook WordPress theme